Cargando…
Monte Carlo dosimetric characterization of the IsoAid ADVANTAGE [Formula: see text] brachytherapy source
For roughly 25 years, [Formula: see text] and [Formula: see text] sources have been used in the treatment of various malignant diseases such as prostate cancer. Various new sources have been marketed and produced to meet the demand for new sources to use in treatment. Recently, IsoAID LLC created th...
Autor principal: | Sowards, Keith T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5722418/ https://www.ncbi.nlm.nih.gov/pubmed/17592461 http://dx.doi.org/10.1120/jacmp.v8i2.2393 |
Ejemplares similares
-
Thermoluminescent and Monte Carlo dosimetry of IR06‐ [Formula: see text] brachytherapy source
por: Saidi, Pooneh, et al.
Publicado: (2011) -
Ocular brachytherapy dosimetry for [Formula: see text] and [Formula: see text] in the presence of gold nanoparticles: a Monte Carlo study
por: Asadi, Somayeh, et al.
Publicado: (2016) -
Monte Carlo investigation of energy response of various detector materials in [Formula: see text] and [Formula: see text] brachytherapy dosimetry
por: Selvam, T. Palani, et al.
Publicado: (2010) -
Monte Carlo‐based beam quality and phantom scatter corrections for solid‐state detectors in [Formula: see text] and [Formula: see text] brachytherapy dosimetry
por: Subhalaxmi, Mishra, et al.
Publicado: (2014) -
Dosimetric characterization of the [Formula: see text] high‐dose‐rate [Formula: see text] brachytherapy source using the AAPM and ESTRO formalism
por: Thanh, Minh‐Tri Ho, et al.
Publicado: (2015)